BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Chromatin, Inc. Closes $10 Million Financing Round, Adds Strategic Investors


10/25/2011 6:42:21 AM

CHICAGO--(BUSINESS WIRE)--Chromatin, Inc., a supplier of renewable biomass feedstocks for energy producers, today announced completion of a $10 million first closing of its Series D financing round that included two strategic investors – BP Ventures and Unilever Technology Ventures – as well as three investors who participated in earlier rounds of financing: Quantitative Investment Holdings, the Malaysian Life Sciences Capital Fund, and Illinois Ventures.

The additional capital will help fund Chromatin’s programs to develop supply chains of energy crop feedstocks for producers of renewable energy. Drawing on capital raised in earlier rounds of venture funding, as well as revenue from its seed and technology sales, Chromatin has launched production-scale tests in electricity-generating plants of its specially bred non-food sorghum crops that can grow on marginal land using less water and fewer chemicals than other energy crops.

“This investment signals BP’s continued commitment to renewable energy feedstocks”, said Justin Adams, Head of BP Ventures. “Chromatin is beginning to develop an exciting bioenergy business with their sorghum platform, and we are interested in understanding how we could deploy their feedstock technologies in our own activities.”

“We are impressed with Chromatin’s extraordinary execution record,” said Andrew Williamson, speaking on behalf of Unilever Technology Ventures. “The company has consistently achieved milestones, exceeded revenue targets, and assembled an international network of sorghum growers and distributors that produce market-leading feedstocks.”

“We’ll look forward to drawing on the insights of BP and Unilever as we bring to market our sustainable biomass feedstocks to companies producing renewable chemicals, fuels and power,” said Daphne Preuss, Chromatin’s CEO. “This market opportunity is growing rapidly, and Chromatin is pleased to have these strategic investors as partners.”

About Chromatin:

Chromatin, Inc. is developing sustainable renewable energy-crop feedstocks for power, fuel and chemical producers. It also is developing high-value next-generation sorghum seeds using its proprietary crop-breeding technology and biotechnology programs. The company licenses its innovative gene-stacking technologies to support the crop-breeding programs of leading agriculture companies, and it applies its technology platforms to its subsidiary, Sorghum Partners LLC, which markets and supplies hybrid sorghum seeds to growers in the US and more than 20 other countries. Chromatin is privately owned and based in Chicago. For additional information, please visit www.chromatininc.com.

Contacts

Chromatin, Inc.

Brad Schwartz, 312-235-3620



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES